Huei Lee Selected Research

Pterygium

4/2014	Vascular endothelial growth factor gene polymorphism and protein expression in the pathogenesis of pterygium.
1/2012	CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells.
7/2010	Effect of TIMP-1 and MMP in pterygium invasion.
6/2010	CYP1A1 gene polymorphisms as a risk factor for pterygium.
4/2010	An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
6/2009	HPV infection and p53 inactivation in pterygium.
5/2008	Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients.
4/2007	Cyclooxygenase 2 expression in pterygium.
12/2006	An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
7/2005	p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huei Lee Research Topics

Disease

90	Neoplasms (Cancer) 01/2022 - 01/2003
46	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2002
33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2003
16	Carcinogenesis 01/2020 - 09/2002
14	Pterygium 04/2014 - 07/2004
12	Adenocarcinoma of Lung 01/2020 - 01/2002
12	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2005
6	Neoplasm Metastasis (Metastasis) 09/2017 - 07/2010
6	Papillomavirus Infections 01/2017 - 01/2005
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2017 - 01/2005
5	Carcinoma (Carcinomatosis) 03/2016 - 08/2003
5	Infections 04/2013 - 08/2005
4	Squamous Cell Carcinoma of Head and Neck 08/2014 - 01/2012
4	Adenocarcinoma 09/2013 - 01/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2006
3	Mouth Neoplasms (Oral Cancer) 08/2017 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 04/2016 - 02/2016
2	Nasopharyngeal Carcinoma 11/2006 - 10/2006
2	Hemorrhage 05/2006 - 05/2005
2	Prostatic Neoplasms (Prostate Cancer) 12/2005 - 05/2005
1	Chronic Disease (Chronic Diseases) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2017

Drug/Important Bio-Agent (IBA)

31	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
25	Proteins (Proteins, Gene)FDA Link 04/2019 - 09/2003
14	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2003
13	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 11/2007
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2010
8	CateninsIBA 10/2020 - 10/2014
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2005
6	Interleukin-10 (Interleukin 10)IBA 09/2013 - 01/2012
5	Phosphotransferases (Kinase)IBA 01/2020 - 03/2005
5	Tyrosine Kinase InhibitorsIBA 01/2018 - 11/2016
5	EnzymesIBA 11/2013 - 01/2005
5	DNA AdductsIBA 01/2013 - 12/2006
5	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2012 - 04/2004
4	Indicators and Reagents (Reagents)IBA 01/2020 - 02/2009
4	PaxillinIBA 01/2020 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2010
4	MethyltransferasesIBA 08/2017 - 08/2005
4	NickelIBA 08/2015 - 07/2006
4	Biological ProductsIBA 04/2013 - 09/2002
4	SmokeIBA 01/2013 - 01/2003
4	CarcinogensIBA 01/2013 - 01/2005
4	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 01/2013 - 12/2006
3	LuciferasesIBA 01/2022 - 04/2010
3	8-Hydroxy-2'-DeoxyguanosineIBA 01/2021 - 09/2013
3	carfilzomibIBA 01/2020 - 01/2016
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 10/2016
3	TL 1IBA 09/2017 - 08/2008
3	XAV939IBA 04/2016 - 01/2016
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2013 - 01/2002
3	Codon (Codons)IBA 04/2013 - 02/2005
3	Interleukin-6 (Interleukin 6)IBA 11/2012 - 08/2008
3	Benzo(a)pyreneIBA 04/2007 - 03/2006
2	Serine (L-Serine)FDA Link 01/2020 - 04/2015
2	hepatitis B virus X proteinIBA 01/2020 - 01/2018
2	PlatinumIBA 01/2020 - 03/2010
2	Cyclin D1IBA 04/2019 - 04/2007
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 05/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 06/2010
2	AZD 6244IBA 01/2018 - 10/2016
2	MicroRNAs (MicroRNA)IBA 12/2016 - 12/2015
2	Superoxide DismutaseIBA 02/2015 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 05/2008
2	Small Interfering RNA (siRNA)IBA 03/2013 - 07/2010
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 10/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 07/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2012 - 07/2007
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2011 - 07/2010
2	InterleukinsIBA 10/2010 - 08/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2008 - 08/2003
2	AminesIBA 07/2007 - 06/2005
2	Protein Isoforms (Isoforms)IBA 01/2007 - 07/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2005 - 03/2005
1	AntioxidantsIBA 01/2021
1	Protein Tyrosine PhosphatasesIBA 04/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	LigandsIBA 01/2018
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	dioscinIBA 01/2018
1	Verteporfin (Visudyne)FDA Link 01/2018
1	B7-H1 AntigenIBA 11/2017
1	VaccinesIBA 09/2017
1	Arginine (L-Arginine)FDA Link 08/2017
1	periodate-oxidized adenosineIBA 08/2017
1	Insulin-Like PeptidesIBA 04/2017
1	Insulin (Novolin)FDA Link 04/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Gemcitabine FDA Link 12/2016

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2020 - 03/2010
4	Therapeutics 01/2018 - 11/2006
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2010 - 10/2006
2	Immunotherapy 09/2017 - 01/2015
2	Aftercare (After-Treatment) 04/2007 - 10/2006
2	Radiotherapy 11/2006 - 10/2006
2	Brachytherapy 11/2006 - 10/2006